Apollo Hospitals Unlocks Value with NewCo Restructure, Shareholders Get 195.2 Shares for Every 100 Held

gained 4.72% after announcing a major restructuring to unlock value by combining its pharmacy, digital health (Apollo 24/7), Keimed (wholesale pharma), and telehealth businesses into a new listed company. For every 100 shares held in Apollo Hospitals, shareholders will get 195.2 shares of the new company, which is expected to be listed in the next 18–21 months. The new entity is projected to generate ₹16,300 crore revenue in FY26 and targets ₹25,000 crore the year after with a 7% EBITDA margin. Apollo will retain a 15% stake, keeping strategic control while giving investors a direct stake in the high-growth healthcare platform. This structure helps remove the holding company discount, improves management focus, and supports stronger capital allocation across verticals—creating long-term value without diluting existing strengths. Follow me for more such updates, Thank You! Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.